BioMarin Pharmaceutical Inc. buy Truist Financial Co.
Start price
15.09.23
/
50%
€82.68
Target price
15.09.24
€131.12
Performance (%)
-0.15%
Price
02.09.24
€82.56
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc. is nearly unchanged. This prediction currently runs until 15.09.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | 2.381% | 2.381% |
iShares Core DAX® | 1.663% | 6.945% |
iShares Nasdaq 100 | 1.261% | 4.883% |
iShares Nikkei 225® | 0.654% | 10.007% |
iShares S&P 500 | 1.403% | 4.350% |
Comments by Truist_Financial_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $140.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€83.00
25.09.23
25.09.23
€131.92
25.09.24
25.09.24
-0.53%
02.09.24
02.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€125.20
13.07.24
13.07.24
3.31%
14.07.24
14.07.24